Novartis AG annual free cash flow for fiscal 2025 was $15.2 billion, an increase of 10.4% from $13.8 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $15.2B | $13.8B | $11.7B | $12.0B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | $5.1B | $2.9B | $1.2B | $5.7B | $6.1B | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NOVN metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS
All NOVN financial statements → Interactive NOVN charts →
About TickerBase · Data methodology & sources · Privacy · Terms